第十届海伦·哈里斯纪念信托基金两年一度会议。

10th Biennial Helene Harris Memorial Trust meeting.

作者信息

Balkwill Frances R, Ashworth Alan, Bast Robert C, Berek Jonathon S, Boyd Jeff, Disis Mary L, Gabra Hani, Gore Martin E, Hamilton Thomas C, Jacobs Ian J, Kaye Stan B, Kohn Elise C, Mills Gordon B, Urban Nicole D

机构信息

Barts and The London Queen Mary's School of Medicine and Dentistry, UK.

出版信息

Cancer Res. 2006 Mar 15;66(6):2904-6. doi: 10.1158/0008-5472.CAN-05-2093.

DOI:10.1158/0008-5472.CAN-05-2093

PMID:16540635

Abstract

Improving the prognosis of ovarian cancer patients is a major challenge to scientists and clinicians. At a recent multidisciplinary meeting in Washington DC, advances in identification of precursor lesions, progress in disease biomarkers and animal models, the promise of nanotechnology, and strategies for manipulation of the innate and adaptive immune response offered prospects for real progress in this difficult-to-treat disease.

摘要

改善卵巢癌患者的预后是科学家和临床医生面临的一项重大挑战。在最近于华盛顿特区召开的一次多学科会议上，前驱病变识别方面的进展、疾病生物标志物和动物模型的进展、纳米技术的前景以及调控先天性和适应性免疫反应的策略，为这种难以治疗的疾病取得实质性进展带来了希望。